Treatment of anticoagulant toxicity involves counteracting the effects of the drug. For vitamin K antagonists, administering vitamin K can help restore clotting factor synthesis. In severe cases, transfusion of fresh frozen plasma or prothrombin complex concentrates might be necessary. For DOACs, specific reversal agents like idarucizumab for dabigatran are used. Supportive care and monitoring are essential components of managing toxicity.
